Alshogran Osama Y, Zhao Wenchen, Krans Elizabeth E, Caritis Steve, Shaik Imam H, Venkataramanan Raman
Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania.
Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan.
Ther Drug Monit. 2025 Jun 1;47(3):413-420. doi: 10.1097/FTD.0000000000001291. Epub 2025 Jan 23.
Buprenorphine (BUP) use is prevalent in pregnant women with opioid use disorder (OUD). Drug monitoring during pregnancy is critical for optimizing dosing regimen and achieving the desired clinical outcomes. Hair can be used as a critical biological matrix for monitoring long-term exposure to drugs. The aim of this study was to optimize the methodology used to quantify BUP and its metabolites in hair samples.
Conditions for hair sample processing (ie, hair washing, incubation temperature, and extraction time) were optimized to maximize extraction recovery. The LC-MS/MS strategy employed here used 4 deuterated internal standards for quantifying BUP and its major metabolites [norbuprenorphine (NBUP), buprenorphine glucuronide (BUP-G), and norbuprenorphine-glucuronide (NBUP-G)] in human hair samples. The optimized conditions were used to measure BUP and its metabolites in hair samples of 5 women undergoing OUD treatment and their neonates.
Unwashed hair samples processed by shaking with acetonitrile for 24 hours at 37 °C showed higher BUP (36%) and NBUP (67%) recovery, compared with those processed by incubation at room temperature. The standard curves showed excellent linearity over 0.05-100 ng/mL for BUP and NBUP and 0.1-200 ng/mL for BUP-G and NBUP-G. The assay was partially validated for reproducibility and accuracy and was successfully used for measuring BUP and metabolites in aforementioned hair samples. BUP was identified in all hair samples, while BUP-G was not. BUP was the primary analyte in maternal hair (median: 38.3 pg/mg; 25-75 percentile: 17-152.4 pg/mg), while NBUP-G was predominant in neonatal hair (median: 28.6 pg/mg; 25%-75% percentile: 1.9-112.8 pg/mg).
The methodology used for quantifying BUP and its metabolites in hair samples of maternal female patients and their neonates is simple, accurate, and reproducible. The developed method may be useful for measuring fetal exposure to BUP during gestation.
丁丙诺啡(BUP)在患有阿片类物质使用障碍(OUD)的孕妇中使用普遍。孕期药物监测对于优化给药方案和实现预期临床结果至关重要。毛发可作为监测长期药物暴露的关键生物基质。本研究的目的是优化用于定量毛发样本中丁丙诺啡及其代谢物的方法。
优化毛发样本处理条件(即毛发清洗、孵育温度和提取时间)以最大化提取回收率。此处采用的液相色谱 - 串联质谱(LC-MS/MS)策略使用4种氘代内标物来定量人毛发样本中的丁丙诺啡及其主要代谢物[去甲丁丙诺啡(NBUP)、丁丙诺啡葡萄糖醛酸苷(BUP-G)和去甲丁丙诺啡葡萄糖醛酸苷(NBUP-G)]。优化后的条件用于测量5名接受OUD治疗的女性及其新生儿毛发样本中的丁丙诺啡及其代谢物。
与在室温下孵育处理的毛发样本相比,在37°C下用乙腈振荡处理24小时的未清洗毛发样本显示出更高的丁丙诺啡(36%)和去甲丁丙诺啡(67%)回收率。标准曲线在0.05 - 100 ng/mL范围内对丁丙诺啡和去甲丁丙诺啡以及在0.1 - 200 ng/mL范围内对丁丙诺啡葡萄糖醛酸苷和去甲丁丙诺啡葡萄糖醛酸苷显示出良好的线性。该测定方法在重现性和准确性方面得到部分验证,并成功用于测量上述毛发样本中的丁丙诺啡及其代谢物。在所有毛发样本中均鉴定出丁丙诺啡,而未鉴定出丁丙诺啡葡萄糖醛酸苷。丁丙诺啡是母体毛发中的主要分析物(中位数:38.3 pg/mg;25 - 75百分位数:17 - 152.4 pg/mg),而去甲丁丙诺啡葡萄糖醛酸苷在新生儿毛发中占主导(中位数:28.6 pg/mg;25% - 75%百分位数:1.9 - 112.8 pg/mg)。
用于定量母体女性患者及其新生儿毛发样本中丁丙诺啡及其代谢物的方法简单、准确且可重现。所开发的方法可能有助于测量孕期胎儿对丁丙诺啡的暴露情况。